Results 81 to 90 of about 3,830 (166)

Rapamycin Autophagy Enhancement for Globotriaosylceramide Clearance

open access: yes
Rapamycin inhibits mTORC1 kinase activity leading to TFEB dephosphorylation and nuclear translocation, dramatically upregulating lysosomal biogenesis genes including LAMP1, LAMP2, and cathepsin D. Enhanced autophagy flux promotes clearance of accumulated Gb3 deposits while rapamycin's anti-inflammatory properties reduce chronic activation of microglia ...
openaire   +1 more source

Generation of diseased and isogenic control human induced pluripotent stem cell lines MHHi043-A & MHHi043-B from a female Fabry disease patient carrying c.644A > G missense mutation

open access: yesStem Cell Research
Fabry disease (FD) is a monogenic, X-linked lysosomal storage disorder originating from mutations in the GLA gene, which encodes alpha-galactosidase A.
Nick Heise   +11 more
doaj   +1 more source

Expression of the verotoxin receptor glycolipid, globotriaosylceramide, in ovarian hyperplasias.

open access: yesOncology research, 1998
The presence of cell surface receptor glycolipid, globotriaosylceramide (Gb3), is essential to confer susceptibility to the E. coli-derived verotoxin (VT). Our earlier studies showed that Gb3 is expressed in ovarian carcinoma cell lines. The Gb3 content of normal ovary, benign and malignant primary ovarian tumors, and their metastases have now been ...
S, Arab   +4 more
openaire   +1 more source

Generation of human induced pluripotent stem cell line MHHi029-A from a male Fabry disease patient carrying c.959A > T mutation

open access: yesStem Cell Research
Fabry disease (FD) is a rare and inherited monogenetic disease caused by mutations in the X-chromosomal alpha-galactosidase A gene GLA concomitant with accumulation of its substrate globotriaosylceramide (Gb3) and multi-organ symptoms.
Christopher Jahn   +10 more
doaj   +1 more source

Generation of an induced pluripotent stem cell line (SMBCi022-A) from a patient with Fabry disease

open access: yesStem Cell Research
Fabry disease (FD) is a systemic disease in which globotriaosylceramide and other naturally occurring glycosphingolipid accumulate in various tissues throughout the body due to mutation of α-galactosidase A (GLA).
Zihan Li   +7 more
doaj   +1 more source

Automated quantification of skin Gb3 load and white matter lesion assessment in Fabry disease. [PDF]

open access: yesOrphanet J Rare Dis
Pfister C   +10 more
europepmc   +1 more source

Generation of two induced pluripotent stem cell lines from Fabry disease patients carrying GLA mutations. [PDF]

open access: yesStem Cell Res
Patra D   +6 more
europepmc   +1 more source

From Shoulder to Heart: Acute Shoulder Pain Leads to a Diagnosis of Fabry Disease. [PDF]

open access: yesJACC Case Rep
Kalaria A   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy